BioSpace News Archive

Scientists from A*STAR’s Singapore Immunology Network (SIgN) and Singapore Bioimaging Consortium (SBIC) have established marmosets as viable in vivo models for investigating human metabolic diseases, infections and immune responses, and developing immune-based therapies.

According to International Agency for Research on Cancer, the number of new cancer cases per year is expected to rise to 23.6 million by 2030 globally. In recent times, cell line development and its applications are considered as potential tools in oncology research.

Pre-clinical testing with new in vitro model could streamline vaccine development

- The financing round was led by top-tier life science venture capitalists Wellington Partners and HBM Healthcare Investments, joined by existing shareholders - The new funds will be used to execute a proof-of-concept clinical program of lead product candidate Adrecizumab in early septic shock - Adrecizumab provides a highly novel approach to treat life-threatening conditions by focusing on the preservation of vascular integrity

AirXpanders, Inc. today announced the 4,000th commercial worldwide placement of AeroForm Tissue Expander was recently implanted in a patient for post-mastectomy, two-stage breast reconstruction.

ARKRAY USA, Inc. announced today the US launch of the GLUCOCARD® Shine Connex Bluetooth® enabled and the GLUCOCARD® Shine Express audio-enabled blood glucose monitoring systems (BGMS).

Topline results for Phase III MicroStat program expected H1 2019

The International Contrast Ultrasound Society (ICUS) applauds the announcement of dramatic changes in payment for contrast-enhanced ultrasound (CEUS) imaging of the abdomen.

New drug Vitrakvi targets specific receptor kinase that promotes tumors

First treatment with a tumor-agnostic indication at the time of initial FDA approval